Missing/wrong data?
Log in to edit
A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers
scientific article
Author/s
author: Bobbi Woolwine, Ebrahim Haroon
Work details
Publication date
January 1, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.